Remission of lupus nephritis: the trajectory of histological response in successfully treated patients

被引:9
作者
Malvar, Ana [1 ]
Alberton, Valeria [1 ]
Lococo, Bruno [1 ]
Lourenco, Maria [1 ]
Martinez, Joaquin [1 ]
Burna, Lucrecia [1 ]
Besso, Celeste [1 ]
Navarro, Jordi [1 ]
Nagaraja, Haikady N. [2 ]
Khatiwada, Aastha [3 ]
Wolf, Bethany [4 ]
Rovin, Brad [5 ]
机构
[1] Hosp Fernandez, Nephrol Unit, Buenos Aires, Argentina
[2] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH USA
[3] Natl Jewish Hlth, Dept Biostat & Bioinformat, Denver, CO USA
[4] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA
[5] Ohio State Univ, Wexner Med Ctr, Internal Med Nephrol, Columbus, OH 43210 USA
来源
LUPUS SCIENCE & MEDICINE | 2023年 / 10卷 / 01期
关键词
lupus nephritis; inflammation; autoimmune diseases; CLASSIFICATION; INCIDENT;
D O I
10.1136/lupus-2023-000932
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThis study investigated changes in kidney histology over time in patients with lupus nephritis (LN) undergoing immunosuppressive treatment.MethodsPatients with proliferative +/- membranous LN were studied. After a diagnostic kidney biopsy (Bx1), patients had protocol biopsy 2 (Bx2) at 9 (6-15) months and protocol biopsy 3 (Bx3) at 42 (28-67) months. Kidney histological activity and chronicity indices (AI, CI) were measured.ResultsAI declined in a biphasic fashion, falling rapidly between Bx1 and Bx2 and then more slowly between Bx2 and Bx3. Patients were divided into those who achieved histological remission, defined as an AI=0 at Bx3 (group 1), and those with persistent histological activity (AI >0) at Bx3 (group 2). The early decline in AI was 1.6 times greater (95% CI 1.30, 1.91) in group 1 than group 2 (p=0.01). Between Bx2 and Bx3, the AI decline was 2.19-fold greater (95% CI 2.09, 2.29) in group 1 versus group 2 (p=7.34x10(-5)). Individual histological components of the AI resolved at different rates. Inflammatory lesions like glomerular crescents, karyorrhexis and necrosis mostly resolved by Bx2, whereas endocapillary hypercellularity, subendothelial hyaline deposits and interstitial inflammation resolved slowly, accounting for residual histological activity at biopsy 3 in group 2. In contrast, CI increased rapidly, by 0.15 units/month between Bx1 and Bx2, then plateaued. There were no differences in the rate of accumulation of chronic damage between group 1 and group 2. The increase in CI was significantly related to the severity of glomerular crescents (p=0.044), subendothelial hyaline deposits (p=0.002) and interstitial inflammation (p=0.015) at Bx1.ConclusionsLN histological activity takes months to years to resolve, providing a rationale for the need of long-term, well-tolerated maintenance immunosuppression. Despite responding, LN kidneys accrue chronic damage early during treatment. This finding provides an explanation for the association of chronic progressive kidney disease with recurrent episodes of LN.
引用
收藏
页数:10
相关论文
共 18 条
  • [1] Lupus nephritis
    Anders, Hans-Joachim
    Saxena, Ramesh
    Zhao, Ming-hui
    Parodis, Ioannis
    Salmon, Jane E.
    Mohan, Chandra
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [2] Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
    Bajema, Ingeborg M.
    Wilhelmus, Suzanne
    Alpers, Charles E.
    Bruijn, Jan A.
    Colvin, Robert B.
    Cook, H. Terence
    D'Agati, Vivette D.
    Ferrario, Franco
    Haas, Mark
    Jennette, J. Charles
    Joh, Kensuke
    Nast, Cynthia C.
    Noel, Laure-Helene
    Rijnink, Emilie C.
    Roberts, Ian S. D.
    Seshan, Surya V.
    Sethi, Sanjeev
    Fogo, Agnes B.
    [J]. KIDNEY INTERNATIONAL, 2018, 93 (04) : 789 - 796
  • [3] A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy
    De Rosa, Marcelo
    Azzato, Francisco
    Toblli, Jorge E.
    De Rosa, Graciela
    Fuentes, Federico
    Nagaraja, Haikady N.
    Nash, Ryan
    Rovin, Brad H.
    [J]. KIDNEY INTERNATIONAL, 2018, 94 (04) : 788 - 794
  • [4] DIAMOND JR, 1990, AM J PATHOL, V137, P1323
  • [5] Worse long-term renal outcome of lupus nephritis patients of African descent living in Europe
    Enfrein, Antoine
    Pirson, Valerie
    Le Guern, Veronique
    Karras, Adexandre
    Tamirou, Farah
    Costedoat-Chalumeau, Nathalie
    Houssiau, Frederic
    [J]. RMD OPEN, 2022, 8 (02):
  • [6] 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
    Fanouriakis, Antonis
    Kostopoulou, Myrto
    Cheema, Kim
    Anders, Hans-Joachim
    Aringer, Martin
    Bajema, Ingeborg
    Boletis, John
    Frangou, Eleni
    Houssiau, Frederic A.
    Hollis, Jane
    Karras, Adexandre
    Marchiori, Francesca
    Marks, Stephen D.
    Moroni, Gabriella
    Mosca, Marta
    Parodis, Ioannis
    Praga, Manuel
    Schneider, Matthias
    Smolen, Josef S.
    Tesar, Vladimir
    Trachana, Maria
    van Vollenhoven, Ronald F.
    Voskuyl, Alexandre E.
    Teng, Y. K. Onno
    van Leew, Bernadette
    Bertsias, George
    Jayne, David
    Boumpas, Dimitrios T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) : 713 - 723
  • [7] Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
    Furie, Richard
    Rovin, Brad H.
    Houssiau, Frederic
    Malvar, Ana
    Teng, Y. K. Onno
    Contreras, Gabriel
    Amoura, Zahir
    Yu, Xueqing
    Mok, Chi-Chiu
    Santiago, Mittermayer B.
    Saxena, Amit
    Green, Yulia
    Ji, Beulah
    Kleoudis, Christi
    Burriss, Susan W.
    Barnett, Carly
    Roth, David A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (12) : 1117 - 1128
  • [8] Kopp JB, 1996, LAB INVEST, V74, P991
  • [9] Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis
    Malvar, Ana
    Alberton, Valeria
    Lococo, Bruno
    Ferrari, Matias
    Delgado, Pamela
    Nagaraja, Haikady N.
    Rovin, Brad H.
    [J]. KIDNEY INTERNATIONAL, 2020, 97 (01) : 156 - 162
  • [10] Histologic versus clinical remission in proliferative lupus nephritis
    Malvar, Ana
    Pirruccio, Paola
    Alberton, Valeria
    Lococo, Bruno
    Recalde, Cecilia
    Fazini, Bernanda
    Nagaraja, Haikady
    Indrakanti, Divya
    Rovin, Brad H.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (08) : 1338 - 1344